2023-25063. Notice of Intent To Grant Exclusive Patent License to Veloxint CIF, Inc.; Tridelphia, WV  

  • Start Preamble

    AGENCY:

    Department of the Army, DoD.

    ACTION:

    Notice of intent.

    SUMMARY:

    The Department of the Army hereby gives notice of its intent to grant to Veloxint CIF, Inc.; a company having its principal place of business at 1142 Middle Creek Road, Tridelphia, WV 26059, an exclusive license.

    DATES:

    Written objections must be filed not later than 15 days following publication of this announcement.

    ADDRESSES:

    Send written objections to U.S. Army Combat Capabilities Development Command Army Research Laboratory, Partnerships Support Office, FCDD–RLB–SS/Jason Craley, Building 4402, 6468 Integrity Ct., Aberdeen Proving Ground, MD 21005–5425 or email to ORTA@arl.army.mil.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Jason Craley, (410) 306–1275, email: ORTA@arl.army.mil.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Department of the Army plans to grant an exclusive license to Veloxint CIF, Inc. in all fields of use pertaining to the following;

    —“Nano-Structured Alloy Material and Method of Synthesizing”, ARL 21–06, US Patent Application No. 17/700,653, Filing Date: 03/22/2022, U.S. Publication No. 2023/0302531A1, Publication Date: 09/28/2023, PCT Application No. PCT/US23/31342, Filing Date: 08/29/2023.

    —“Oxidation and Corrosion Resistant Nanostructured Copper-Based Metallic Systems”, ARL 22–18, US Patent Application No. 18/127,398, Filing Date: 03/28/2023, PCT Application No. PCT/US23/32206, Filing Date: 09/07/2023.

    The prospective exclusive license may be granted unless within fifteen (15) days from the date of this published notice, the U.S. Army Combat Capabilities Development Command Army Research Laboratory receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). Competing applications completed and received by the U.S. Army Combat Capabilities Development Command Army Research Laboratory within fifteen (15) days from the date of this published notice will also be treated as objections to the grant of the contemplated exclusive license.

    Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552.

    Start Signature

    James W. Satterwhite Jr.,

    Army Federal Register Liaison Officer.

    End Signature End Supplemental Information

    [FR Doc. 2023–25063 Filed 11–13–23; 8:45 am]

    BILLING CODE 3711–02–P

Document Information

Published:
11/14/2023
Department:
Army Department
Entry Type:
Notice
Action:
Notice of intent.
Document Number:
2023-25063
Dates:
Written objections must be filed not later than 15 days following publication of this announcement.
Pages:
77996-77996 (1 pages)
PDF File:
2023-25063.pdf